Open AccessPharmacodynamics of teicoplanin against MRSA
Author(s) -
V. Ramos-Martín,
Adam Johnson,
Laura McEntee,
Nicola Farrington,
K. Padmore,
Pier Giorgio Cojutti,
Federico Pea,
Michael Neely,
William Hope
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx289
Subject(s) - teicoplanin , pharmacodynamics , medicine , methicillin resistant staphylococcus aureus , vancomycin , staphylococcus aureus , pharmacology , pharmacokinetics , biology , bacteria , genetics
The overall study aim was to identify the relevant preclinical teicoplanin pharmacokinetic (PK)/pharmacodynamic (PD) indices to predict efficacy and suppression of resistance in MRSA infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom